HOORAY FOR TILRAY-
Tilray Adds New CBD Drinks And Busch Beer Names
On Aug. 24, Tilray debuted its
new carbonated CBD drinks under its Solei brand in Ontario, Quebec and Alberta, Canada.
Tilray announced on Aug. 8 that it entered into an agreement to
buy eight beer brands from
Anheuser-Busch(
BUD) for an undisclosed cash amount. Brands in the deal include
Shock Top, Breckenridge Brewery,
Blue Point Brewing Company, Square Mile Cider Company and HiBall Energy.
The transaction includes breweries and brewpubs associated with the brands, according to
the Wall Street Journal. The deal is expected to close sometime this year.
Tilray Brands subsidiary
Montauk Brewing announced on Aug. 2 that its craft beers will be available in Philadelphia, Scranton and the Lehigh Valley in Pennsylvania.
Losses Getting Smaller While Sales Grow
Tilray posted an adjusted loss of 1 cent per share in its fiscal Q4 earnings release July 26, which equaled last year's same quarter. This beat FactSet's forecast of a four-cent loss.
Quarterly sales rose 20%, a huge improvement over the 4%, 7% and 9% declines in the prior three quarters. Revenue got a boost from the company's strong 43% alcohol beverage net revenue increase, while cannabis net revenue grew 21% vs. the prior year's same quarter.
The company has saved $22 million out of its $30 million cost optimization plan that it announced in Q4 2022.
Tilray's $43 million adjusted free cash flow far exceeded the negative $24 million in the prior year's quarter.
"During the 2023 fiscal year, we delivered on our commitment to generate positive adjusted free cash flow across all business segments, and executed against our strategic plan to grow revenue, drive operating efficiencies, and improve margins and profitability, all while investing in our industry-leading brands," said Irwin D. Simon, Tilray Brands' chairman and CEO.
Tilray expects to achieve full-year fiscal 2024 adjusted EBITDA targets of $68 million to $78 million, representing growth of 11% to 27% as compared with fiscal year 2023, with positive adjusted free cash flow in 2024.
Tilray held on to its top spot in the
Canadian cannabis market with an
8.5% market share in a recent report.